Literature DB >> 15638299

Malignant bronchial carcinoid tumor metastatic to the pituitary in a thyroid carcinoma patient: successful treatment with surgery, radiotherapy and somatostatin analog.

Ilan Shimon1, Moshe Hadani, Dvora Nass, S Tzila Zwas.   

Abstract

A carcinoid pituitary metastasis is very rare, and is reported scarcely in a few patients. We describe an unusual case of metastatic atypical bronchial carcinoid to the anterior pituitary gland in a 47-year-old male who presented with bitemporal hemianopsia and hypopituitarism. His primary bronchial carcinoid was resected two years previously. Foci of metastatic papillary thyroid carcinoma were also identified in the lung resected for the bronchial carcinoid. He thereby underwent total thyroidectomy followed by radioiodine ablative treatment. Transsphenoidal partial removal of the suprasellar mass was performed, and atypical carcinoid metastasis was identified. He received conventional fractionated sellar radiotherapy, which was supplemented with octreotide (Sandostatin LAR) injections following a positive pituitary uptake on octreotide scan. This treatment suppressed his elevated 5-HIAA urinary excretion to a normal level. His vision has returned to normal and the pituitary mass diminished in size.

Entities:  

Mesh:

Year:  2004        PMID: 15638299     DOI: 10.1023/b:pitu.0000044627.63261.b4

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  21 in total

Review 1.  Malignant carcinoid tumor of the anterior mediastinum metastasis to a prolactin-secreting pituitary adenoma: a case report.

Authors:  T Abe; K Matsumoto; M Iida; M Hayashi; N Sanno; R Y Osamura
Journal:  Surg Neurol       Date:  1997-10

2.  Papillary carcinoma of thyroid metastatic to the pituitary gland.

Authors:  C D Bell; K Kovacs; E Horvath; H Smythe; S Asa
Journal:  Arch Pathol Lab Med       Date:  2001-07       Impact factor: 5.534

3.  The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment.

Authors:  W Shi; K D Buchanan; C F Johnston; C Larkin; Y L Ong; R Ferguson; J Laird
Journal:  Clin Endocrinol (Oxf)       Date:  1998-03       Impact factor: 3.478

4.  Thyroid carcinoma metastatic to pituitary.

Authors:  J J Sziklas; J Mathews; R P Spencer; R J Rosenberg; M T Ergin; B F Bower
Journal:  J Nucl Med       Date:  1985-09       Impact factor: 10.057

Review 5.  Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment.

Authors:  Kjell Oberg
Journal:  Curr Opin Oncol       Date:  2002-01       Impact factor: 3.645

6.  Papillary thyroid carcinoma metastatic to the pituitary gland.

Authors:  U S Masiukiewicz; I A Nakchbandi; A F Stewart; S E Inzucchi
Journal:  Thyroid       Date:  1999-10       Impact factor: 6.568

7.  Somatostatin-receptor imaging in the localization of endocrine tumors.

Authors:  S W Lamberts; W H Bakker; J C Reubi; E P Krenning
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

8.  Bronchial carcinoid tumor with skin metastases.

Authors:  E J Rudner; C Lentz; J Brown
Journal:  Arch Dermatol       Date:  1965-07

9.  A metastatic pituitary carcinoid tumor successfully treated with gamma knife radiosurgery.

Authors:  M C Huang; L S Lee; D M Ho; H Cheng; W Y Chung; C I Huang; C Y Hsiao; D H Pan
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2001-07

10.  Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.

Authors:  A S Abutaily; B J Addis; W R Roche
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

View more
  8 in total

Review 1.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

Review 2.  Bronchial carcinoid tumors metastatic to the sella turcica and review of the literature.

Authors:  Olga Moshkin; Fabio Rotondo; Bernd W Scheithauer; Mark Soares; Claire Coire; Harley S Smyth; Miklos Goth; Eva Horvath; Kalman Kovacs
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 3.  Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review.

Authors:  Umberto Goglia; Diego Ferone; Marilena Sidoti; Renato Spaziante; Patrizia Dadati; Jean-Luis Ravetti; Giuseppe Villa; Lisa Bodei; Giovanni Paganelli; Francesco Minuto; Massimo Giusti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 4.  Ectopic acromegaly due to growth hormone releasing hormone.

Authors:  Ali A Ghazi; Alireza Amirbaigloo; Azizollah Abbasi Dezfooli; Navid Saadat; Siavash Ghazi; Marina Pourafkari; Farrokh Tirgari; Dheepti Dhall; Serguei Bannykh; Shlomo Melmed; Odelia Cooper
Journal:  Endocrine       Date:  2012-09-15       Impact factor: 3.633

5.  Metastatic pancreatic neuroendocrine tumor presenting as a pituitary space occupying lesion: a case report.

Authors:  Chamutal Gur; Gadi Lalazar; Asher Salmon; Victoria Dubiner; David J Gross
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

6.  Typical bronchial carcinoid metastasizing to the brain: a case presentation.

Authors:  Simon B Zeichner; Mike Cusnir; Michael Francavilla; Alicia Hirzel
Journal:  Case Rep Oncol       Date:  2011-12-23

7.  Pituitary metastasis: a rare condition.

Authors:  Aida Javanbakht; Massimo D'Apuzzo; Behnam Badie; Behrouz Salehian
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

Review 8.  Pituitary metastases from neuroendocrine neoplasms: case report and narrative review.

Authors:  Alberto Ragni; Alice Nervo; Mauro Papotti; Nunzia Prencipe; Francesca Retta; Daniela Rosso; Marta Cacciani; Giuseppe Zamboni; Francesco Zenga; Silvia Uccella; Paola Cassoni; Marco Gallo; Alessandro Piovesan; Emanuela Arvat
Journal:  Pituitary       Date:  2021-08-03       Impact factor: 4.107

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.